The molecular cloning workflow requires QC checkpoints both before and after restriction endonuclease digestion to minimize ...
Colossal Biosciences expands its de-extinction mission by acquiring Viagen, the world leader in animal cloning and species ...
Colossal’s purchase of ViaGen, known for cloning pets of celebrities, bolsters the biotech firm’s tools for de-extinction and conservation.
Viagen Pets and Equine is a biotechnology company that will produce genetic twins of customers' pets and livestock. But its conservation efforts are what attracted Colossal.